Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Identify Areas for Clinical Differentiation To stand out clinically amidst increasing competition, manufacturers are moving beyond weight loss to explore expanding indications, novel clinical pathways, and additional therapeutic benefits
Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company
Emerging preclinical research has identified GLP-1 receptors in various immune cells and tissues, leading to scientific interest in potential anti-inflammatory properties
In the meantime, focus on the non-scale victories like more energy, better bloodwork, your clothes fitting better
Besides Kentucky, other Southeastern states with high rates of GLP-1 use include Alabama (1.7%), West Virginia (1.7%), and Georgia (1.6%)
Notably, even after stopping the drug, some weight loss benefit persisted long-term, albeit much weaker than with continued treatment
